amarantus bioscience holding
Transactions by AMARANTUS BIOSCIENCE HOLDING (AMBS) in the last 6 months
Amarantus Bioscience Holdings, Inc (OTCPK:AMBS) announced that it has entered into a securities purchase agreement for a private placement of 3,300 shares of series E 12% convertible preferred shares at a price of $909.09 per share for gross proceeds of $3,000,000 on November 7, 2014. Each series E preferred share has a stated value of $1,000 and will be issued at a 10% original issue discount. The transaction included participation from existing investor Dominion Capital ...
|No competitor information is available for AMBS.|
|View Industry Companies|
|Price/Cash Flow||NM||Not Meaningful|